Activities of ceragenin CSA-13 against established biofilms in an in vitro model of catheter decolonization

Anti-Infective Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2009, Pages 290-294

  Pollard, Jacob ^a   Wright, Jon ^a   Feng, Yanshu ^a   Geng, Dianliang ^a   Genberg, Carl ^b   Savage, Paul B ^a  

^a Brigham Young University   (United States)

^b Ceragenix Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CSA 13; EDETIC ACID; EGTAZIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BIOFILM; CATHETER INFECTION; DIALYSIS CATHETER; DISINFECTION; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 73549102461     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152109789760225     Document Type: Article

References (33)

1. Hall-Stoodley, L.; Stoodley, P. Evolving concepts in biofilm infections. Cell. Microbiol., 2009, 11, 1034-1043.
2. Estrela, A. B.; Heck, M. G.; Abraham, W. R. Novel approaches to control biofilm infections. Curr. Med. Chem., 2009, 16, 1512-1530.
3. Pavithra, D.; Doble, M. Biofilm formation, bacterial adhesion and host response on polymeric implants - issues and prevention. Biomed. Mater., 2008, 3, 34003.
4. Donlan, R. M. Biofilms on central venous catheters: is eradication possible? Curr. Top. Microbiol. Immunol. 2008, 322, 133-161.
5. Marcos, J. F.; Gandia, M. Antimicrobial peptides: to membranes and beyond. Expert Opin. Drug Discov., 2009, 4, 659-671.
6. Durr, U. H. N.; Sudheendra, U. S.; Ramamoorthy, A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta, 2006, 1758, 1408-1425.
7. Pütsep, K.; Carlsson, G.; Boman, H. G.; Andersson, M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet, 2002, 360, 1144-1149.
8. Howell, M. D. The role of human beta defensins and cathelicidins in atopic dermatitis. Curr. Opin. Allergy Clin. Immunol., 2007, 7, 413-417.
9. Ali A. S. M.; Townes, C. L.; Hall, J.; Pickard, R. S. Maintaining a sterile urinary tract: the role of antimicrobial peptides. J. Urol., 2009, 182, 21-28.
10. Gombart, A. F.; Bhan, I.; Borregaard, N.; Tamez, H.; Camargo, C. A.; Koeffler, H. P.; Thadhani, R. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin. Infect. Dis., 2009, 48, 418-424.
11. Mookherjee, N.; Hancock, R. E. W. Cationic host defense peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci., 2007, 64, 922-933.
12. Adair, C. G.; Gorman, S. P.; Feron, B. M.; Byers, L. M.; Jones, D. S.; Goldsmith, C. E.; Moore, J. E.; Kerr, J. R.; Curran, M. D.; Hogg, G.; Webb, C. H.; McCarthy, G. J.; Milligan, K. R. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med., 1999, 25, 1072-1076.
13. Mer, M.; Duse, A. G.; Galpin J. S.; Richards, G. A. Central venous catheterization: a prospective, randomized, double-blind study. Clin. Appl. Thromb. Hemost. 2009, 15, 19-26.
14. Zhang, L. J.; Falla, T. J. Antimicrobial peptides: therapeutic potential. Exp. Opin. Pharmacother. 2006, 7, 653-663.
15. Nizet, V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 2006, 8, 11-26.
16. Lai, X.-Z.; Feng, Y.; Pollard, J.; Chin, J. N.; Rybak, M. J.; Bucki, R.; Epand, R. F.; Epand, R. M.; Savage, P. B. Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc. Chem. Res. 2008, 41, 1233-1240.
17. Beathard, G. A.; Urbanes, A. Infection associated with tunneled hemodialysis catheters. Semin. Dial., 2008, 21, 528-538.
18. Lee, J.-Y.; Ko, K. S.; Peck, K. R.; Oh, W. S.; Song, J.-H. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J. Antimicrob. Chemother. 2006, 57, 1110-1115.
19. LePlante, K. L.; Mermel, L. A. In vitro activity of daptoycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol. Dial. Transplant. 2007, 22, 2239-2246.
20. Lee, M. Y.; Ko, K. S.; Song, J.-H.; Peck, K. R. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. J. Antimicrob. Chemother. 2007, 60, 782-787.
21. Steczko, J.; Ash, S. R.; Nivens, D. E.; Brewer, L.; Winger, R. K. Microbial inactivation properties of a new antimicrobial/ antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrol. Dial. Transplant. 2009, 24, 1937-1945.
22. Qu, Y.; Istavan, T. S.; Daley, A. J.; Rouch, D. A.; Deighton, M. A. Comparisons of various antimicrobial agents as catheter lock solutions: preference of ethanol in eradication of coagulase-negative staphylococcal biofilms. J. Med. Microbiol. 2009, 58, 442-450.
23. Abbas, S. A.; Haloob, I. A.; Taylor, S. L.; Curry, E. M.; King, B. B.; van der Merwe, W. M.; Marshall, M. R. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infections and bacterial resistance: a quality improvement report. Am. J. Kidney Dis. 2009, 53, 492-502.
24. Li, C.; Budge, L. P.; Driscoll, C. D.; Willardson, B. M.; Allman, G. W.; Savage, P. B. Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gram-negative bacteria. J. Am. Chem. Soc. 1999, 121, 931-940.
25. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S16. CLSI, Wayne, A, USA, 2006.
26. Goeres, D. M.; Loetterle, L. R.; Hamilton, M. A.; Murga, R.; Kirby, D. W.; Donlan, R. M. Statistical assessment of a laboratory method for growing biofilms. Microbiology, 2005, 151, 757-762.
27. Raad, I. I.; Hachem, R. Y.; Hanna, H. A.; Fang, X.; Jiang, Y.; Dvorak, T.; Sherertz, R. J.; Kontoyiannis, D. P. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int. J. Antimicrob. Agents 2008, 32, 515-518.
28. Turakhia, M. H.; Cooksey, K. E.; Characklis, W. G. Influence of a calcium-specific chelant on biofilm removal. Appl. Envir. Microbiol. 1983, 46, 1236-1238.
29. Lynch, A. S.; Robertson, G. T. Bacterial and fungal biofilm infections. Annu. Rev. Med. 2008, 59, 415-428.
30. Johnson, L. B.; Jose, J.; Yousif, F.; Pawlak, J.; Saravolatz, L. D. Prevalence of colonization with community-associated methicillinresistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect. Control Hosp. Epidemiol. 2009, 30, 4-8.
31. Fluck, R.; Wilson, J.; Davies, J.; Blackburn, R.; O'Donoghue, D.; Tomson, C. R. V. UK renal registry 11th annual report (December 2008): Chapter 12 epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving replacement therapy in England in 2007. Nephron Clin. Pract., 2009, 111, c247-c256.
32. Rosenthal, V. D.; Make, D. G.; Mehta, A.; Alverez-Moreno, C.; Leblebicioglu, H.; Higuera, F.; Cuellar, L. E.; Madani, N.; Mitrev, Z.; Duenas, L.; Navoa-Ng, J. A.; Garcell, H. G.; Raka, L.; Hidalgo, R. F.; Medeiros, E. A.; Kanj, S. S.; Abubakar, S.; Nercelles, P.; Pratesi, R. D. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am. J. Infect. Control, 2008, 36, 627-637.
33. Driffield, K.; Miller, K.; Bostock, J. M.; O'Neill, A. J.; Chopra, I. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrob. Chemother., 2008, 61, 1053-1056.